Last Posted: Jun-24-2019 11AM
Last Posted: Jun 20, 2019
- Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics.
Hathaway Quincy A et al. Cardiovascular diabetology 2019 Jun 18(1) 78 - Drug may slow development of type 1 diabetes
NIH Research Matters, June 18, 2019 - The CADASIL Scale-J, A Modified Scale to Prioritize Access to Genetic Testing for Japanese CADASIL-Suspected Patients.
Koizumi Takashi et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019 Jun 28(6) 1431-1439 - Evaluating the predictability of medical conditions from social media posts.
Merchant Raina M et al. PloS one 2019 14(6) e0215476 - Highlights from the nutrition guidelines for cystic fibrosis in Australia and New Zealand.
van der Haak Natalie et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2019 Jun - A Digital-First Model of Diabetes Care.
Cafazzo Joseph A et al. Diabetes technology & therapeutics 2019 Jun 21(S2) S252-S258 - Enhancing Diabetes Self-Management Through Collection and Visualization of Data From Multiple Mobile Health Technologies: Protocol for a Development and Feasibility Trial.
Shaw Ryan J et al. JMIR research protocols 2019 Jun 8(6) e13517 - Evaluating Reach, Acceptability, Utility, and Engagement with An App-Based Intervention to Improve Medication Adherence in Patients with Coronary Heart Disease in the MedApp-CHD Study: A Mixed-Methods Evaluation.
Santo Karla et al. Medical sciences (Basel, Switzerland) 2019 Jun 7(6) - Valuing Citizen Access to Digital Health Services: Applied Value-Based Outcomes in the Canadian Context and Tools for Modernizing Health Systems.
Hackett Christina et al. Journal of medical Internet research 2019 Jun 21(6) e12277 - An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
KC Herold et al, NEJM, June 9, 2019
.jpeg)
No hay comentarios:
Publicar un comentario